Sep 10, 2020
ReShape Lifesciences(TM) Announces Positive Preclinical Results for Its Investigational Diabetes Bloc-Stim Neuromodulation Device
Jul 31, 2018
ReShape Lifesciences Announces European Trial to Support CE-Mark of ReShape Vest
Jul 11, 2018
ReShape Lifesciences Announces $2.7 Million Registered Direct Offering Priced At-the-Market
Jul 10, 2018
ReShape Lifesciences Expands Intra-gastric Balloon Business to Include Brigham and Women's Hospital in Boston
Jun 27, 2018
ReShape Lifesciences Announces Acceptance of Abstract to be Presented at IFSO Annual Conference
Jun 20, 2018
ReShape Lifesciences Announces $1.5 Million Registered Direct Offering Priced At-the-Market
Jun 19, 2018
ReShape Lifesciences Receives USPTO Issue Notification for Patent Covering its ReShape Vest
Jun 07, 2018
ReShape Lifesciences Announces $1.5 Million Registered Direct Offering Priced At-the-Market
Jun 06, 2018
ReShape Lifesciences Assembles World Class Scientific Advisory Board
Jun 05, 2018
ReShape Lifesciences Announces New Patent Grant Expanding its Bioelectronic and Neuromodulation Portfolio
Jun 04, 2018
ReShape Lifesciences Provides Update on FDA Letter to Health Care Providers Related to Intragastric Balloons
Jun 01, 2018
ReShape Lifesciences Announces 1-for-15 Reverse Stock Split
May 24, 2018
ReShape Lifesciences to Participate at Digestive Disease Week 2018
May 16, 2018
ReShape Lifesciences Trains Eleven Surgeons in Saudi Arabia
May 14, 2018
ReShape Lifesciences Announces Record Revenue for First Quarter 2018
May 10, 2018
ReShape Lifesciences Announces Submission for Approval of ReShape Balloon(TM) in Canada
Apr 30, 2018
ReShape Lifesciences to Host First Quarter 2018 Conference Call on May 14, 2018
Apr 24, 2018
ReShape Lifesciences Continues to Grow Presence in Middle East with Distribution in Bahrain
Apr 18, 2018
Forty Surgeons Trained on ReShape Balloon at Hands-On Course During SAGES 2018
Apr 10, 2018
ReShape Lifesciences Pioneers New Bio-electronic Technology for Treatment of Type 2 Diabetes